z-logo
open-access-imgOpen Access
Nir2, a Novel Regulator of Cell Morphogenesis
Author(s) -
Dan Tian,
Vladimir Litvak,
Maria Toledo-Rodriguez,
Shari Carmon,
Sima Lev
Publication year - 2002
Publication title -
molecular and cellular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.14
H-Index - 327
eISSN - 1067-8824
pISSN - 0270-7306
DOI - 10.1128/mcb.22.8.2650-2662.2002
Subject(s) - biology , rhoa , microbiology and biotechnology , morphogenesis , neurite , actin cytoskeleton , gtpase , guanine nucleotide exchange factor , cytoskeleton , stress fiber , lysophosphatidic acid , cdc42 , rac gtp binding proteins , small gtpase , actin , rac1 , cell , signal transduction , biochemistry , focal adhesion , receptor , gene , in vitro
Cell morphogenesis requires dynamic reorganization of the actin cytoskeleton, a process that is tightly regulated by the Rho family of small GTPases. These GTPases act as molecular switches by shuttling between their inactive GDP-bound and active GTP-bound forms. Here we show that Nir2, a novel protein related to Drosophila retinal degeneration B (RdgB), markedly affects cell morphology through a novel Rho-inhibitory domain (Rid) which resides in its N-terminal region. Rid exhibits sequence homology with the Rho-binding site of formin-homology (FH) proteins and leads to an apparent loss of F-actin staining when ectopically expressed in mammalian cells. We also show that Rid inhibits Rho-mediated stress fiber formation and lysophosphatidic acid-induced RhoA activation. Biochemical studies demonstrated that Nir2, via Rid, preferentially binds to the inactive GDP-bound form of the small GTPase Rho. Microinjection of antibodies against Nir2 into neuronal cells markedly attenuates neurite extension, whereas overexpression of Nir2 in these cells attenuates Rho-mediated neurite retraction. These results implicate Nir2 as a novel regulator of the small GTPase Rho in actin cytoskeleton reorganization and cell morphogenesis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here